Old Web
English
Sign In
Acemap
>
authorDetail
>
Cheri E. Klein
Cheri E. Klein
University of Illinois at Chicago
Pharmacology
Pharmacokinetics
Irinotecan
Medicine
Oncology
4
Papers
148
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study
2006
Cancer Chemotherapy and Pharmacology
Cheri E. Klein
Helen Kastrissios
Antonius A. Miller
Donna Hollis
Daohai Yu
Gary L. Rosner
David L. Grinblatt
Richard A. Larson
Mark J. Ratain
Show All
Source
Cite
Save
Citations (24)
Population pharmacokinetic model for irinotecan and two of its metabolites, SN‐38 and SN‐38 glucuronide
2002
Clinical Pharmacology & Therapeutics
Cheri E. Klein
Elora Gupta
Joel M. Reid
Pamela J. Atherton
Jeff A Sloan
Henry Clement Pitot
Mark J. Ratain
Helen Kastrissios
Show All
Source
Cite
Save
Citations (66)
Phase 1 study of irinotecan (CPT-11) in patients with abnormal liver or renal function or with prior pelvic radiation therapy
2001
Alan P. Venook
Cheri E. Klein
Helen Kastrissios
C. Leichman
Donna Hollis
Raymond J. Hohl
M. Villalona
Mark J. Ratain
Show All
Source
Cite
Save
Citations (2)
Phase I and Pharmacokinetic Study of Irinotecan and Docetaxel in Patients With Advanced Solid Tumors: Preliminary Evidence of Clinical Activity
2000
Journal of Clinical Oncology
Alex A. Adjei
Cheri E. Klein
Helen Kastrissios
Richard M. Goldberg
Steven Robert Alberts
Henry Clement Pitot
Jeff A Sloan
Joel M. Reid
Lorelei J. Hanson
Pamela J. Atherton
Joseph Rubin
Charles Erlichman
Show All
Source
Cite
Save
Citations (56)
1